2019-08-05
Small
0 Inquired
0 Favorited
ConnectService Type:
T - Technology & Patents
Industry:
Pharmaceuticals and Chemical IntermediatesEnvironmental Protection and Comprehensive Resource UtilizationChemical Engineering Technology Research and Development and Process Package
Country / Region:
China
Company Type:
Private enterpriseHigh-tech enterpriseSpecialized Sophisticated and Novel Enterprises
Registered Capital:
100 million RMB
corporate capability: Process Technology Development、Chemical Plant Revamping、Plant O&M & Commissioning、Plant Startup、Process Package Design、Design Optimization
Inner Mongolia Huaxin Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research and development, production, and sales of chemical active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, positioning itself as a specialized manufacturer in the fields of chiral drugs and green manufacturing processes. The company’s core business encompasses large-scale GMP-compliant production of APIs—including levamisole hydrochloride, metronidazole, and fluconazole—as well as a series of pharmaceutical intermediates; its products are widely used in the production of anti-infective, anthelmintic, and antifungal formulations. Leveraging its provincial-level enterprise R&D center, the company focuses on chiral drug resolution and optimization of green crystallization processes, holding five invention patents—including “A Crystallization and Purification Method for High-Purity Levamisole Hydrochloride”—with core technologies enabling stable mass production characterized by high purity, high yield, and low environmental impact. The company holds a “Pharmaceutical Production License” (No. Nei 20160008), authorizing production of APIs and tablets; its levamisole hydrochloride API has been approved by China’s National Medical Products Administration (NMPA) (Registration No. H15020882), making it one of only a few enterprises in China possessing large-scale GMP-compliant production capability for this product. Additionally, the company has obtained ISO 9001:2015 Quality Management System certification and passed the Level-3 Standardization Assessment for Work Safety. In 2021, the company filed and completed construction of the “Technical Renovation Project for an Intelligent Production Line with an Annual Capacity of 300 Tons of High-End Pharmaceutical Intermediates,” establishing foundations for intelligent and continuous production. Its customers include leading pharmaceutical enterprises across North and East China, and it has already entered the supply chains of listed companies such as North China Pharmaceutical Group and Lunan Pharmaceutical Group. Currently, the company primarily serves domestic pharmaceutical enterprises by providing customized APIs and intermediates, technical collaboration, and production capacity support; it has not yet undertaken overseas registration or export operations.
Connect
More SuppliersEverlight Suzhou Advanced Chemicals Ltd.
3
0
T - Technology & Patents
Suzhou Xiaxiang Biomedical Co., Ltd.
2
0
T - Technology & Patents
RI MING COMPUTER ACCESSORY(SHANGHAI)CO.,LTD.
2
0
T - Technology & Patents
P - Procurement
Jiangsu Jiehui Intelligent Technology Co., Ltd.
4
0
T - Technology & Patents
P - Procurement
C - Construction
Shandong Tianhang Machinery Equipment Co., Ltd.
3
0
T - Technology & Patents
P - Procurement























